Nilu Perera, MBBS^*, Ashleigh P Scott, MBBS, FRACP, FRCPA, Stewart Hunt, MBBS, FRACP, FRCPA^*, Cameron Curley, MBBS, FRACP, FRCPA^*, Siok-Keen Tey, MBBS, PhD, FRACP, FRCPA, Jason Butler, MBBS, FRACP, MMedSc, Andrea S Henden, BSc, MBBS, FRACP, FRCPA, PhD^*, Elango S. Pillai, FRACP, FRCPA, MBBS, Cheryl Hutchins, PhD^*, Kari Louise Mudie^* and Glen A Kennedy, MBBS, FRACP, FRCPA^*

Department of Haematology and BMT, Royal Brisbane and Women's Hospital, Brisbane, Australia

Issa F. Khouri, MD¹, Hyunsoo Hwang^2*, Sattva S. Neelapu, MD³, Xuemei Wang, MS^2*, Chitra Hosing, MD¹, Sairah Ahmed, MD⁴, Partow Kebriaei, MD¹, May Daher, MD¹, Amanda L. Olson, MD¹, Paolo Anderlini, MD¹, Jin S. Im, MD, PhD⁵, Jason Westin, MD³, Elizabeth J Shpall, MD¹, Richard E Champlin, MD¹ and Loretta J. Nastoupil, MD⁶

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma/Myeloma and Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX
⁵Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas,, Houston, TX
⁶Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Stefanie Kreutmair^1,2*, Maximilian M Schaefer^1*, Sebastian Stolz^3*, Carla Merten^1*, Can Ulutekin^1*, Florian Ingelfinger^1*, Susanne Unger^1*, Chiara Alberti^1*, Tobias Wertheimer^1*, Aakriti Sethi^1*, Thorsten Zenz³, Markus G Manz³, Antonia Maria Susanne Müller^3,4,5*, Corinne C Widmer^3,5,6* and Burkhard Becher^1,5*

¹Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland
²German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Freiburg, Germany
³Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland
⁴Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria
⁵These authors contributed equally, Zurich, Switzerland
⁶Department of Hematology, University Hospital Basel, Zurich, Switzerland

Kai Rejeski, MD¹, Doris K. Hansen, MD², Radhika Bansal, MBBS^3*, Pierre Sesques, MD^4*, Sikander Ailawadhi⁵, Jennifer M. Logue, MD, BS, BA⁶, Ciara L. Freeman, MSc, FRCPath, MBBChir, MRCP⁶, Melissa Alsina, MD**⁷, Sebastian Theurich, MD^1*, Frederick L. Locke, MD⁸, Emmanuel Bachy, MD, PhD^4*, Michael D. Jain, MD, PhD², Yi Lin, MD, PhD⁹ and Marion Subklewe, MD¹⁰

¹Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
²Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
⁵Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
⁶Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁷Moffitt Cancer Center, Tampa, FL
⁸Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁹Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
¹⁰Department of Medicine III (Hematology/Oncology), LMU University Hospital Munich, Muenchen, Germany

Bertram Glass^1,2*, Anna Sureda³, Ariane Boumendil, PhD^4*, Peter Dreger, MD⁵, Paolo Corradini, MD⁶, Ron Ram, MD⁷, Nicolaus Kroeger, MD⁸, Luca Castagna, MD^9*, Thomas Pabst, MD¹⁰, Mi Kwon, MD, PhD^11*, Gerald Wulf, MD^12*, Alejandro Martín García-Sancho, MD, PhD^13*, Carlos Solano, MD, PhD¹⁴, Matthias Stelljes, MD¹⁵, Hans Christian Reinhardt, MD¹⁶, Marie Thérèse Rubio, MD, PhD^17*, Ram Malladi^18*, Didier Blaise, MD, PhD¹⁹, Caroline Besley, FRCPath, PhD^20*, Edouard Forcade, MD, PhD²¹, Malte von Bonin, MD^22*, Jürgen Finke, MD, PhD²³, Inken Hilgendorf, MD^24*, Joaquín Martínez-López, MD, PhD^25*, Jose A. Perez-Simon, MD, PhD²⁶, Wolfgang Bethge, MD^27* and Norbert Schmitz, MD^28*

¹Clinic for Hematology and Cell Therapy, Helios Klinik Berlin-Buch, Berlin, Germany
²EBMT Working Party Lymphoma, Paris, France
³Hematology Department, Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain
⁴EBMT Lymphoma Working Party Paris Office, Paris, France
⁵Internal Medicine V - Hematology, Oncology & Rheumatology, University of Heidelberg, Heidelberg, Germany
⁶Università degli Studi di Milano and Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCSS) Istituto Nazionale dei Tumori, Milan, Italy
⁷Bone Marrow Transplant Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
⁸Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁹Instituto Clinico Humanitas, Rozzano, MI, Italy
¹⁰University Hospital Bern, Inselspital, Bern, Switzerland
¹¹Department of Hematology, Hospital General Universitario Gregorio Marañón, Gregorio Marañon Health Research Institute, Madrid, Spain
¹²Department of Hematology and Oncology, Georg-August-University of Göttingen, Göttingen, Germany
¹³Department of Hematology, Hospital Clínico Universitario de Salamanca, IBSAL, Salamanca, Spain
¹⁴Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain
¹⁵Dept. of Internal Medicine A, University Hospital Münster, Münster, Germany
¹⁶Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany, Essen, Germany
¹⁷Service Hématologie, CHRU Brabois, Nancy, France
¹⁸Centre for Clinical Heamatology, Queen Elizabeth Hosptial, Birmingham, United Kingdom
¹⁹Hematology Department, Institut Paoli-Calmettes, Marseille, France
²⁰University Hospitals Bristol, Bristol, United Kingdom
²¹CHU Bordeaux, Hôpital Haut-Leveque, Pessac, France, Pessac, France
²²Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Saxony, Germany
²³Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
²⁴Klinik für Innere Medizin II, Abt. Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Jena, Germany
²⁵Hospital Univ. 12 de Octubre, Complutense University, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain
²⁶Hospital Universitario Virgen del Rocio/Instituto Biomedicina Sevilla, Seville, Spain
²⁷Hematology & Oncology, Universitaet Tuebingen, Medizinische Klinik, Tuebingen, Germany
²⁸Department of Medicine A, University Hospital Münster, Münster, Germany

Frederick L. Locke, MD¹, Zhen-Huan Hu, MPH^2*, Tanya Siddiqi, MD³, Caron A. Jacobson, MD⁴, Sarah Nikiforow, MD, PhD⁴, Sairah Ahmed, MD⁵, David B. Miklos, MD, PhD⁶, Yi Lin, MD, PhD⁷, Matthew A. Lunning, DO, FACP⁸, Brian T. Hill, MD, PhD⁹, Armin Ghobadi, MD¹⁰, Harry Miao, MD, PhD^2*, Shilpa Shahani, MD^2*, Clare Spooner, MBBS, BSc^2*, Christine Fu, PhD^2*, Anik R. Patel, PhD^2*, Hairong Xu, MD, PhD^2* and Marcelo C Pasquini, MD, MS¹¹

¹Moffitt Cancer Center, Tampa, FL
²Kite, a Gilead Company, Santa Monica, CA
³Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁴Dana-Farber Cancer Institute, Boston, MA
⁵The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
⁷Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁸University of Nebraska, Omaha, NE
⁹Cleveland Clinic Foundation, Cleveland, OH
¹⁰Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
¹¹Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI

Frederick L. Locke, MD¹, Sattva S. Neelapu, MD², Markqayne D. Ray, PharmD, MBA^3*, Eve H Limbrick-Oldfield^4*, Sally W Wade, MPH^5*, Steve Kanters, PhD, MSc^4*, Anik R. Patel, PhD^3* and Olalekan O. Oluwole, MBBS⁶

¹H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX
³Kite, A Gilead Company, Santa Monica, CA
⁴RainCity Analytics, Vancouver, BC, Canada
⁵Wade Outcomes Research and Consulting, Salt Lake City, UT
⁶Vanderbilt University Medical Center, Nashville, TN

Maeve A O'Reilly¹, Robin Sanderson^2*, William Wilson^3*, David Burns^4*, Caroline Besley, FRCPath, PhD^5*, Thomas Creasey^6*, Ben Uttenthal^7*, Johnathon Elliot^8*, Claire Roddie^1,9*, Andrea Kuhnl^2*, Shankara Paneesha⁴, Frances Seymour^10*, Sunil Iyengar^11*, Lourdes Rubio^12*, Matthew Wilson¹³, Stephen Boyle^2*, Kathleen PL Cheok¹, Graham P. Collins, MBBS, MA, MRCP, FRCPath, DPhil¹⁴, Rod Johnson^10* and Andrew K. McMillan, MD¹⁵

¹University College London Hospital NHS Foundation Trust, London, United Kingdom
²King's College Hospital, London, United Kingdom
³Cancer Research UK and UCL Cancer Trials Centre University College London, London, United Kingdom
⁴University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
⁵University Hospitals Bristol, Bristol, United Kingdom
⁶Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
⁷Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
⁸The Christie NHS Foundation Trust, Manchester, United Kingdom
⁹UCL Cancer Institute, University College London, London, United Kingdom
¹⁰Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
¹¹Royal Marsden Hospital, London, United Kingdom
¹²Manchester Royal Infirmary, Manchester, United Kingdom
¹³Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
¹⁴Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, ENG, United Kingdom
¹⁵Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

Viktoria Blumenberg, MD^1,2,3, Galina Busch^2*, Stephan Baumann^2*, Regina Jitschin, PhD, MD^4,5*, Michael Winkelmann, MD^6*, Konstantin Hellwig, MD^7*, Kai Rejeski, MD^1,3,8, Lisa Frölich^1,3*, Benjamin Tast^1*, Christian Schmidt, MD^1*, Friederike Hildebrandt, MD^1*, Franziska Dekorsy, MD^9*, Christian Schmidkonz, MD^10*, Tobias Bäuerle, MD^7*, Wolfgang G. Kunz, MD^6*, Fabian Mueller, MD^5,11*, Dimitrios Mougiakakos, MD^4,5, Michael von Bergwelt, Prof. Dr.^1,12*, Veit Bücklein, MD^1,2,3*, Andreas Mackensen, MD^4,5*, Simon Voelkl, PhD^4,5* and Marion Subklewe, MD^3,8,13

¹Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
²Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
³German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany
⁴Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
⁵Bavarian Center for Cancer Research (BZKF), partner site Erlangen, Erlangen, Germany
⁶Department of Radiology, University Hospital, LMU Munich, Munich, Germany
⁷Department of Radiology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany
⁸Laboratory for Translational Cancer Immunology, Gene Center, LMU, Munich, Germany
⁹Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany
¹⁰Department of Nuclear Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany
¹¹Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany
¹²German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Munich, Heidelberg, Germany
¹³Department of Medicine III (Hematology/Oncology), LMU University Hospital Munich, Muenchen, Germany

Lauren S Jiménez-Kurlander, MD^1*, Gerald Behr, MD^2*, Nancy J Bunin, MD^3*, Ekaterina Doubrovina, MD, PhD^4*, Rajani Dinavahi, MD⁵, Laurence Gamelin, MD, PhD^5*, Armin Ghobadi, MD⁶, Leo Mascarenhas, MBBS, MD, MS^7*, Sarah Nikiforow, MD, PhD^8*, Richard J O'Reilly, MD⁴, Anita Price, MD^2*, Barry Shulkin, MD^9*, Ashok Srinivasan, MD^10,11*, Stephanie Suser^12*, Justin Wahlstrom, MD^13*, Baodong Xing, PhD^5* and Susan Prockop, MD¹

¹Department of Pediatrics, Boston Children's Hospital/Dana Farber Cancer Institute, Boston, MA
²Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY
³Cellular Therapy and Transplant Section, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
⁴Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Atara Biotherapeutics Inc., Thousand Oaks, CA
⁶Center for Gene and Cellular Immunotherapy (CGCI), Washington University School of Medicine, St. Louis, MO
⁷Children's Center for Cancer and Blood Diseases, Children's Hospital of Los Angeles, Los Angeles, CA
⁸Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁹Department of Diagnostic Imaging, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, TN
¹⁰Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
¹¹Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN
¹²Department of Pediatrics, BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹³Atara Biotherapeutics, South San Francisco, CA

Daniel Fürst, MD^1,2*, Christine Neuchel, PhD^1,2*, Adela Neagoie, MD^3*, Elisa Amann^1,2*, Immanuel Rode, PhD^1,2*, Angela Krauss^1,2*, Hubert Schrezenmeier, MD^1,2, Verena Wais, MD^3*, Hartmut Döhner, MD³, Andreas Viardot, MD³ and Elisa Sala, MD^3*

¹Institute of Transfusion Medicine, University of Ulm, Ulm, Germany
²Institute of Clinical Transfusion Medicine and Immunohematology, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessia and University Hospital Ulm, Ulm, Germany
³Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany

Tassja J Spindler^*, Fiona Ruiz^*, Tiffany Jehng^*, Hanna Ding^*, Norma Guzman-Becerra, MS^*, Shahram Khanzadeh^*, Xiaoming Li^*, Laurence Gamelin, MD, PhD^*, Jason A. Dubovsky^* and Cokey Nguyen^*

Atara Biotherapeutics Inc., Thousand Oaks, CA

Ameya Shrinivas Kunte, MD¹, Nico Gagelmann^2*, Anita Badbaran^2*, Carolina Berger^3*, Radwan Massoud, MD^1*, Evgeny Klyuchnikov^1*, Christine Wolschke, MD^1*, Dietlinde Janson, MD^1*, Ulrike Fritsche-Friedland^3*, Boris Fehse, PhD^3*, Nicolaus Kroeger, MD¹ and Francis A. Ayuk, MD^1*

¹Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
²University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
³Department of Stem Cell Transplantation, Research Department Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Fareed Khawaja, MBBS¹, Rishab Prakash, BS^2*, Joseph Sassine, MD^3*, Guy Handley, MD^4*, Tracy VanWieren^2*, Georgios Angelidakis^2*, Swaminathan P. Iyer, MD⁵, Jeremy L. Ramdial, MD⁶, Sairah Ahmed, MD⁷, Yago Nieto, MD⁸, Amy Spallone^2*, Ella J. Ariza-Heredia, MD^9* and Roy Chemaly, MD, MPH^10*

¹Department of Infectious Diseases, MD Anderson Cancer Center, Houston, TX
²The University of Texas MD Anderson Cancer Center, Houston, TX
³Oklahoma University College of Medicine, Oklahoma City, OK
⁴University of South Florida Morsani College of Medicine, Tampa, FL
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma/Myeloma and Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX
⁸Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
⁹MD Anderson Cancer Center, Houston, TX
¹⁰Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX

Niels WCJ Van De Donk, MD¹, Mounzer Agha², Adam D Cohen, MD³, Yael C Cohen^4*, Sébastien Anguille^5*, Tessa Kerre^6*, Wilfried W.H. Roeloffzen, MD, PhD^7*, Deepu Madduri, MD^8*, Jordan M Schecter⁹, Kevin C De Braganca^9*, Carolyn C Jackson^9*, Helen Varsos^9*, Pankaj Mistry^10*, Tito Roccia^11*, Xiaoying Xu^9*, Katherine Li^12*, Enrique Zudaire¹², Christina Corsale^9*, Muhammad Akram^13*, Dong Geng^13*, Lida Pacaud^13*, Pieter Sonneveld, MD¹⁴ and Sonja Zweegman, MD, PhD¹

¹Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
²UPMC Hillman Cancer Center, Pittsburgh, PA
³University of Pennsylvania, Philadelphia, PA
⁴Tel Aviv Sourasky (Ichilov) Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁵Vaccine and Infectious Disease Institute, University of Antwerp, Edegem, Belgium, Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium
⁶Ghent University Hospital, Ghent, Belgium
⁷University Medical Center Groningen, Groningen, Netherlands
⁸Mount Sinai Medical Center, New York, NY
⁹Janssen Research & Development, Raritan, NJ
¹⁰Janssen Research & Development, High Wycombe, United Kingdom
¹¹Janssen Global Services, Raritan, NJ
¹²Janssen Research & Development, Spring House, PA
¹³Legend Biotech USA, Piscataway, NJ
¹⁴Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands

Omar Alexis Castaneda Puglianini, MD¹, Lauren C. Peres, PhD, MPH^2*, Doris K. Hansen, MD³, Taiga Nishihori, MD³, Ariel F Grajales-Cruz, MD⁴, Brandon J. Blue, MD⁵, Jason Brayer, MD, PhD⁴, Ciara L. Freeman, MSc, FRCPath, MBBChir, MRCP¹, Kenneth H. Shain, MD, PhD⁴, Hien D. Liu, MD³, Jose Ochoa, MD³, Frederick L. Locke, MD⁶, Rachid C. Baz, MD⁷ and Melissa Alsina, MD**⁸

¹Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL
³Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
⁴Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁵Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁶H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁷Department of Malignant Hematology, Moffitt cancer center and research institute, tampa, FL
⁸Moffitt Cancer Center, Tampa, FL

Choquet Sylvain, MD^1*, Magali Le Garff-Tavernier^2*, Laetitia Souchet^3*, Damien Roos Weil, MD, PhD^4*, Veronique Morel, MD^5*, Madalina Uzunov, MD^6*, Carole Metz^7*, Stephanie Nguyen Quoc, MDPC^8*, Nathalie Jacque^9*, Nicolas Gauthier, MD^10*, Lise Willems, MD, PhD^11*, Agathe Waultier, MD^12*, Celia Salanoubat^13*, Roch Houot, MD, PhD^14*, Renata Ursu^15*, Maryline Barrie^16*, Guido Ahle, MD^17*, Carole Soussain, MD¹⁸, Marion Alcantara, MD^19* and Caroline Houillier, MD^20*

¹Clinical Hematology, La Pitie Salpetriere Hospital, APHP-Sorbonne Universite, Paris, France, France
²Sorbonne Université-INSERM UMRS 1138, AP-HP, Hopital Pitie-Salpetriere, Service d’Hématologie Biologique, Paris, France
³Pitie-Salpetriere Hospital - APHP Sorbonne Universite, Paris, France
⁴Hematology department, Sorbonne Université Hôpital Pitié Salpêtrière APHP, Paris, FRA
⁵Hematology Department, Pitié Salpétrière University Hospital, Paris, France
⁶Department of Hematology, University Hospital La Pitié SalpetrièRe, Paris, FRA
⁷Pharmacy, Groupe Hospitalier Pitié-salpêtrièRe, APHP, Paris, FRA
⁸Department of hematology, La Pitié University Hospital, Paris, France
⁹Service d'Hematologie Clinique, Hôpital Pitié Salpêtrière, APHP, Paris, France
¹⁰Service d’Hématologie, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
¹¹Assistance Publique-Hôpitaux de Paris.Centre-Université Paris Cité, Hôpital Cochin, Department of Hematology, Paris, France
¹²Department of Hematology, CHU Nimes, Nimes, France
¹³CH Sud Francilien, Hematology, CORBEIL ESSONNES, FRA
¹⁴Department of Hematology, Rennes University Hospital, Rennes, France
¹⁵Assistance Publique -hopitaux De Paris, Paris, FRA
¹⁶neuro oncology, AP hopitaux de Marseille, Marseille, France
¹⁷Neurology Department, CH Colmar, Colmar, France
¹⁸Hematology Department, Rene Huguenin Hospital, Institut Curie, Saint-Cloud, France
¹⁹Institut Curie, Paris, France
²⁰LOC network, La Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Paris, France

Jian-Qing Mi^1*, Wanhong Zhao^2*, Hongmei Jing^3*, Weijun Fu⁴, Jianda Hu⁵, Lijuan Chen^6*, Yiwen Zhang^7*, Dan Yao^8*, Hui Li^8*, Jordan M Schecter⁹, Fan Yang^8*, Huabin Sun^9*, Sen Hong Zhuang^8*, Da Xu^7*, Tracy Luo^7*, Xiaohu Fan^10*, Ting Niu¹¹, Jie Jin¹² and Sai-Juan Chen¹

¹Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
²The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, ShaanXi, Shanxi, China
³Peking University Third Hospital, Beijing, China
⁴Shanghai Changzheng Hospital and Department of Hematology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, China
⁵Fujian Medical University Union Hospital, Fuzhou, Fujian, China
⁶Jiangsu Province Hospital, Nanjing, Jiangsu, China
⁷Legend Biotech China, Nanjing, Jiangsu, China
⁸Janssen China Research & Development, Shanghai, China
⁹Janssen Research & Development, Raritan, NJ
¹⁰Xi’an Jiaotong University Institute of Gene and Cell Therapy, Xi’an, ShaanXi, China
¹¹West China Hospital of Sichuan University, Chengdu, China
¹²First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China

Mark P Hamilton, MD^1,2,3, Felicia C Liu-Fei^3*, Stefan K. Alig, MD⁴, John Tamaresis, PhD^5*, Mohammad Shahrokh Esfahani, PhD^6*, Zinaida Good, PhD^3,5,7, Brian Sworder, MD, PhD⁸, Joseph Schroers-Martin, MD⁶, Chih Long Liu, PhD^6*, Freja Tang Severinsen, BSc^2,9*, Paul J Hanson, PhD^3*, Ying Lu, PhD^5*, Robert Lowsky, MD², Robert S. Negrin, MD², Everett H Meyer, MD, PhD^2*, Melody Smith, MD, MS², Sushma Bharadwaj, MD, MS^10*, Judith A Shizuru, MD, PhD^2,11, Surbhi Sidana, MD^2,3, Parveen Shiraz, MD², Andrew R. Rezvani, MD², Laura J. Johnston, MD², Wen-Kai Weng, MD, PhD², Sally Arai, MD¹², Lori Muffly, MD^2,3, Saurabh Dahiya, MD², Maximilian Diehn, MD, PhD^13*, David M. Kurtz, MD, PhD⁶, Bita Sahaf, PhD^3*, Crystal L. Mackall, MD^3,7,14, Matthew J Frank, MD, PhD¹⁵, David B. Miklos, MD, PhD^2,3 and Ash A. Alizadeh, MD, PhD^11,16

¹Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
²Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
³Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA
⁴Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
⁵Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA
⁶Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
⁷Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
⁸Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
⁹Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, AL, Denmark
¹⁰Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
¹¹Institute for Stem Cell Biology and Regenerative Medicine, Stanford University Medical Center, Stanford, CA
¹²Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University Medical Center, Stanford, CA
¹³Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
¹⁴Divisions of Hematology and Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
¹⁵Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
¹⁶Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, San Mateo, CA

Peihao Zheng, MD^1*, Rui Liu^2*, Teng Xu^3*, Fan Yang^2*, Shaomei Feng, MD^1*, Yuelu Guo, MD^1*, Lixia Ma, MD^1*, Hui Shi, MD^1*, Hongwei Yu^3*, Biping Deng^4*, Xiaoyan Ke, MD, PHD^1* and Kai Hu, M.D., Ph.D.^1*

¹Department of Adult Lymphoma, Beijing GoBroad Boren Hospital, Beijing, China
²Department of Adult Lymphoma, Beijing GoBroad Boren Hospital, Beijing, AL, China
³Department of Data Statistics, Beijing GoBroad Boren Hospital, Beijing, China
⁴Cytology Laboratory, Beijing GoBroad Boren Hospital, Beijing, China

Belén Sierro^*, Clara Beatriz Garcia-Calderon, PhD^*, Luzalba Sanoja-Flores, PhD^*, Victoria Ruiz-Maldonado^*, Javier Delgado Serrano, MD^*, Agueda Molinos-Quintana^*, Juan Luis Reguera, MD^*, Beatriz Guijarro-Albaladejo^*, Marta Reinoso-Segura^*, Estefania Garcia-Guerrero, PhD^*, Jose A. Perez-Simon, MD, PhD and Teresa Caballero, PhD^*

Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain